MGC Pharma receives approval for dementia trial
PERTH: MGC Pharmaceuticals (ASX:MXC) is one step closer to trialling its promising GMP certified CogniCannTM
PERTH: MGC Pharmaceuticals (ASX:MXC) is one step closer to trialling its promising GMP certified CogniCannTM
FEATURED
Retirement apartments to be woven into mixed-use development
Thousands of dementia sufferers are being denied new miracle drug
Property group reveals revised mixed-use housing development plans
Best retirement housing design for Global Awards shortlisted
Vision for affordable and sustainable multigenerational housing canvassed by experts
Intergenerational social housing boom in particular now underway
INNOVATION
